Kyowa Kirin
Pharmaceutical Company
Based in NJ
AI Overview
With $140K in lobbying spend across 4 quarterly filings, Kyowa Kirin is an active lobbying client. Their lobbying covers 2 issue areas.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2025 | $140K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Kyowa Kirin disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Pharmacy, Trade
FDA modernization policy issues; General issues related to rare disease and clinical trials; General issues related to diagnostics for patients with rare diseases; Issues related to drug pricing; Issu
Issues Related to Trade
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.